Not only was Aβ peptide identified first from amyloid deposited in vascular walls in AD and Down’s syndrome patients [25], but the APP mutations were also identified for the first time in a familial form of CAA called hereditary cerebral haemorrhage with amyloidosis – Dutch type (HCHWA-D). Here, APP is linked to Alzheimer disease.